z-logo
Premium
What will it take to refute the possible safety signal for dolutegravir and neural tube defects?
Author(s) -
Zash RM
Publication year - 2019
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.15864
Subject(s) - dolutegravir , pharmacovigilance , medicine , pregnancy , neural tube , obstetrics , pediatrics , neural tube defect , human immunodeficiency virus (hiv) , antiretroviral therapy , fetus , family medicine , viral load , adverse effect , genetics , embryo , biology , microbiology and biotechnology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom